NEU 6.41% $15.27 neuren pharmaceuticals limited

Some holders seem quite impatient just because the share price...

  1. 2,649 Posts.
    lightbulb Created with Sketch. 142
    Some holders seem quite impatient just because the share price has retreated. BOD shouldn't have to put out a bunch of fluff announcements to try and calm the nerves. If you think it's that undervalued you should be happy about being able to buy more at these prices, no? I certainly didn't expect 6 months ago we'd be in the mid teens again but will gladly make the most of it.

    We all know what news to expect in the upcoming months, within the next 4 weeks most likely we'll know a lot more about the strategy going forward to phase III. I trust the team knows what they are doing. Do you?
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.